ZETIA (ezetimibe) – an inhibitor of intestinal cholesterol (and related phytosterol) absorption commonly used to certain types of hyperlipidemias. Specifically, Ezetimibe works to reduce blood cholesterol by inhibiting the absorption of cholesterol by the small intestine. FDA approved uses: Zetia is as an adjunct to diet to: Reduce elevated total-C, LDL-C, Apo B, and non-HDL-C […]
VYVANSE (lisdexamfetamine dimesylate) – a central nervous system (CNS) stimulant commonly used to treat symptoms of attention deficit hyperactivity disorder (ADHD). Amphetamines block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space. The precise mechanism of action of how amphetamines and other CNS […]
LUCENTIS (ranibizumab injection) – an biologic monoclonal antibody commonly used to treat certain eye conditions. Ranibizumab binds to the receptor binding site of active forms of VEGF-A, including the biologically active, cleaved form of this molecule, VEGF110. VEGF-A has been shown to cause neovascularization and leakage in models of ocular angiogenesis and vascular occlusion and […]
LOVENOX (enoxaparin) – a low molecular weight heparin commonly used in clinical settings where anticoagulation is needed. Low molecular weight heparins exert their clinical effect through the antithrombotic properties of heparins. FDA approved uses: Lovenox is indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical […]